Where do Bristol-Myers Squibb's ratios come from?

Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	70.5%-0.6pp	71.1%+1.6pp	69.5%-0.8pp	70.3%-0.2pp	70.5%-0.6pp
Net margin	15%+0.4pp	14.6%+2.2pp	12.4%+2.0pp	10.4%-0.8pp	11.2%+29.9pp
EBITDA margin	27.2%-0.5pp	27.7%+1.1pp	26.6%-0.5pp	27.1%-2.3pp	29.4%+27.3pp
Free cash flow margin	24.6%-2.1pp	26.7%-5.2pp	31.9%+1.3pp	30.6%+3.1pp	27.5%-1.4pp
Returns
Return on equity	38.8%-1.7pp	40.5%+7.1pp	33.4%+4.5pp	28.9%-2.7pp	31.6%+71.0pp
Return on assets	8.1%+0.4pp	7.7%+1.5pp	6.3%+1.0pp	5.3%-0.3pp	5.6%+15.2pp
Return on invested capital	13%+0.5pp	12.5%+2.0pp	10.6%+2.2pp	8.3%-0.5pp	8.8%+23.5pp
Efficiency
Asset turnover	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Inventory turnover	5.3×0.0×	5.3×+0.5×	4.8×-0.1×	4.9×-0.1×	5×-0.4×
Liquidity
Current ratio	1.4×+0.2×	1.3×0.0×	1.3×+0.1×	1.2×-0.1×	1.3×0.0×
Quick ratio	1.3×+0.1×	1.1×0.0×	1.2×+0.1×	1.1×-0.1×	1.2×0.0×
Cash ratio	0.5×+0.1×	0.4×-0.1×	0.6×+0.1×	0.5×0.0×	0.5×0.0×
Leverage
Debt-to-equity	2.2×-0.3×	2.6×-0.1×	2.7×-0.2×	2.8×0.0×	2.9×-0.3×
Debt-to-assets	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Net debt / EBITDA	2.7×-0.1×	2.8×+0.1×	2.6×-0.2×	2.8×+0.1×	2.8×-36.3×
Valuation
Market capitalization	$123.83B+12.8%	$109.81B+19.6%	$91.8B-4.1%	$95.71B-22.9%	$124.1B+8.2%
Enterprise value	$158.92B+8.3%	$146.74B+17.1%	$125.26B-5.5%	$132.49B-18.8%	$163.11B+4.8%
Price / earnings	17×+1.5×	15.6×+0.2×	15.4×-3.8×	19.2×-4.0×	23.2×—
Price / sales	2.6×+0.3×	2.3×+0.4×	1.9×-0.1×	2×-0.6×	2.6×+0.2×
Price / book	6.2×+0.2×	5.9×+1.0×	4.9×-0.5×	5.5×-1.6×	7.1×+0.1×
EV / EBITDA	12×+1.0×	11×+1.2×	9.8×-0.5×	10.3×-1.4×	11.6×-137×
EV / sales	3.3×+0.2×	3×+0.4×	2.6×-0.2×	2.8×-0.6×	3.4×+0.2×
Free cash flow yield	9.6%-2.1pp	11.7%-5.0pp	16.7%+1.4pp	15.2%+4.7pp	10.5%-1.6pp
Earnings yield	5.9%-0.5pp	6.4%-0.1pp	6.5%+1.3pp	5.2%+0.9pp	4.3%+12.2pp
Dividend yield	4.1%-0.5pp	4.6%-0.9pp	5.4%+0.3pp	5.2%+1.2pp	4%-0.3pp
PEG ratio	0.5×—	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Bristol-Myers Squibb.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Bristol-Myers Squibb's ratios come from?: Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.